Dr. Joseph Kozikowski to serve in Chief Technology Officer and Medical Director roles for an emerging leader in cancer therapy.
FRAMINGHAM, MA – August 1, 2000 – Clinivation, Inc. announced today that clinivation Founder and CEO Joseph Kozikowski, M.D. has been appointed Chief Technology Officer and Medical Director of ViaCirq, Inc., an emerging leader in cancer therapy, with headquarters in Pittsburgh, PA.
In this role, Dr. Kozikowski will lead and support certain medical, product development, regulatory, and business development initiatives for ViaCirq’s hyperthermic chemotherapy product lines for intraperitoneal hyperthermic chemotherapy and isolated limb perfusion.
Quotes & Commentary:
“It is an honor and my pleasure to serve ViaCirq in this important role, and I thank ViaCirq Chief Executive Glenn Keeling and the Board of Directors for their vision and support,” said clinivation Founder and CEO Joseph Kozikowski, M.D.
About ViaCirq:
ViaCirq, Inc., the developer and marketer of the ThermoChemTM HT System, which delivers intraperitoneal hyperthermia, has standardized the procedure, enabling other medical institutions to provide this potentially life-extending treatment. The ThermoChem HT System is currently being used by 13 medical centers nationwide.
